Imagine printing a complex biological map directly onto a computer chip. Instead of painstakingly placing one molecule at a time, this method lets molecules organize themselves into thousands of precise spots automatically. It is like switching from hand-painting a single portrait to using a high-speed industrial printer for thousands of images at once.
Integrating biological elements into miniaturized semiconductor sensors is currently too difficult and expensive for mass production. This has limited the availability of affordable, multiplexed biosensors for healthcare and environmental monitoring.
A bio-intelligent manufacturing process for silicon-based biosensors, including protocols for photolithographic DNA synthesis on wafers with cycle times ≤ 2 min/base.
If you are a medical device manufacturer dealing with the high cost of producing multi-biomarker tests — this project developed a bio-inspired self-assembly process that allows the simultaneous deposition of tens of different biomolecules into thousands of positions on a silicon wafer. This enables the creation of sensors that measure multiple health markers from a single drop of blood or urine.
If you are a food quality testing lab dealing with slow detection of mold toxins or antibiotics — this project developed a wafer-level biofunctionalization process that lowers production costs for bioMEMS sensors. This allows for rapid, repeatable, and low-cost screening of food samples at an industrial scale.
If you are a water utility company dealing with expensive water quality monitoring equipment — this project developed a new encapsulation process for silicon-based biosensors. This makes the sensors cost-effective for mass manufacturing and deployment in the field to monitor water quality.
The project uses wafer-level biofunctionalization and a new encapsulation process to significantly lower the production costs of bioMEMS sensors, making them suitable for mass manufacturing.
Yes, the bio-intelligent processes are designed to be industrial and repeatable, allowing for the simultaneous deposition of biomolecules across thousands of positions on a silicon wafer.
Based on available project data, specific IP or licensing terms are not provided, but the project involves a consortium of 6 partners including 3 industry players.
The technology integrates bio-inspired assembly directly into semiconductor manufacturing, utilizing silicon wafers and photolithographic synthesis to marry MEMS sensors with biotechnology.
The project period runs from 2022-09-01 to 2026-02-28, indicating the development phase is currently active.
The consortium is highly commercially oriented, with a 50% industry ratio consisting of 3 industrial partners (including 2 SMEs) and 3 research/university entities across 4 countries (AT, DE, FI, PT). This balance suggests a strong focus on translating lab-scale bio-assembly into a viable industrial manufacturing process.
Contact TEKNOLOGIAN TUTKIMUSKESKUS VTT OY in Finland
Contact us to connect with the BIOASSEMBLER consortium for licensing and integration opportunities.
